RA Capital Management’s scPharmaceuticals SCPH Stock Holding History

RA Capital Management’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,856,904	Closed	-$13.3M	–	67
2022 Q4	$13.3M	Buy	+1,856,904	New	+$11.3M	0.27%	48
2022 Q2	–	Sell	-2,658,583	Closed	-$15.1M	–	97
2022 Q1	$15.1M	Sell	2,658,583 -33,187	-1%	-$163K	0.33%	61
2021 Q4	$13.5M	Sell	2,691,770 -39,400	-1%	-$217K	0.24%	70
2021 Q3	$18.2M	Hold	2,731,170	–	–	0.25%	63
2021 Q2	$16.7M	Hold	2,731,170	–	–	0.27%	60
2021 Q1	$18.2M	Sell	2,731,170 -787,828	-22%	-$5.4M	0.27%	56
2020 Q4	$18.6M	Hold	3,518,998	–	–	0.26%	58
2020 Q3	$26.2M	Hold	3,518,998	–	–	0.48%	44
2020 Q2	$25.9M	Hold	3,518,998	–	–	0.5%	37
2020 Q1	$26M	Buy	3,518,998 +271,993	+8%	+$1.97M	0.82%	31
2019 Q4	$18.4M	Hold	3,247,005	–	–	0.56%	27
2019 Q3	$19.1M	Hold	3,247,005	–	–	1.14%	19
2019 Q2	$10.4M	Buy	3,247,005 +389,862	+14%	+$1.28M	0.56%	24
2019 Q1	$8.57M	Hold	2,857,143	–	–	0.37%	28
2018 Q4	$10.7M	Hold	2,857,143	–	–	0.63%	24
2018 Q3	$16.8M	Hold	2,857,143	–	–	0.9%	22
2018 Q2	$16.2M	Hold	2,857,143	–	–	1.05%	20
2018 Q1	$35.4M	Hold	2,857,143	–	–	2.71%	9
2017 Q4	$34.5M	Buy	+2,857,143	New	+$40.3M	2.89%	11

Other funds holding SCPH

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

RA Capital Management's SCPH Position: Q1 2023 in Review

RA Capital Management sold out of scPharmaceuticals (SCPH) in Q1 2023, closing a stake of 1,856,904 shares — an estimated $13.3M sold.

RA Capital Management first reported a position in SCPH in Q4 2017 and held it in 19 quarters. The position peaked at $35.4M in Q1 2018. 62 funds tracked by Wall St. Rank hold SCPH as of Q1 2023.

RA Capital Management reported no remaining scPharmaceuticals position as of Q1 2023 after selling out during the quarter.
RA Capital Management sold 1,856,904 scPharmaceuticals shares in Q1 2023, an estimated $13.3M.
RA Capital Management first reported a position in scPharmaceuticals in Q4 2017 and held it in 19 quarters.
RA Capital Management's scPharmaceuticals position peaked at $35.4M in Q1 2018.
62 funds tracked by Wall St. Rank held scPharmaceuticals as of Q1 2023.

Based on RA Capital Management's 13F filing for Q1 2023, filed 15 May 2023.